Insider trades

James Kihara, Officer of Acadia Pharmaceuticals ACAD, has filed 0 purchases and 27 sales on the open market. Over the past 12 months that comes to a net sale of $602.8K. The latest trade was on 06/26.

James Kihara

Principal Accounting Officer
First filing
23/02/27
Trades
81 trades
Buys / sales
0 / 27
12-month net buying
−$602.8K
Last trade
06/26

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2606/2911,421 sh$26.08$297,859.68−46.6%
Open-market sale05/2605/275,401 sh$21.18$114,393.18−18.1%
Open-market sale05/0405/051,332 sh$21.79$29,024.28−4.4%
Open-market sale04/0704/071,030 sh$22.20$22,866−3.6%
ACAD
Open-market sale03/25–03/2603/261,942 sh3 trades$21.57avg.$41,895.32−6.7%
Open-market sale25/11/1825/11/194,084 sh$23.69$96,749.96−14.0%
ACAD
Open-market sale10b5-1 plan25/05/1625/05/194,000 sh2 trades$22.50avg.$90,000−16.4%
Open-market sale25/05/0225/05/021,327 sh$14.60$19,374.2−5.3%
Open-market sale25/04/0825/04/081,028 sh$14.82$15,234.96−4.4%
Open-market sale25/03/2625/03/261,095 sh$17.05$18,669.75−4.9%
Open-market sale25/02/2425/02/25475 sh$19.96$9,481−2.3%
Open-market sale24/11/1924/11/194,073 sh$16.81$68,467.13−17.0%
Open-market sale24/05/0224/05/031,326 sh$16.94$22,462.44−8.4%
ACAD
Open-market sale24/04/0824/04/091,790 sh2 trades$17.87avg.$31,987.3−12.0%
Open-market sale24/02/2624/02/27474 sh$24.67$11,693.58−4.0%
Open-market sale10b5-1 plan23/12/1523/12/152,000 sh$28.30$56,600−15.4%
Open-market sale23/11/2023/11/211,985 sh$22.64$44,940.4−13.2%
Open-market sale10b5-1 plan23/09/1523/09/192,000 sh$25.88$51,760−15.7%
Open-market sale10b5-1 plan23/06/1523/06/162,000 sh$24.15$48,300−17.9%
Open-market sale23/05/1723/05/195,947 sh$22.50$133,807.5−34.8%